Clinical Trial Update: Treatment of Early Systemic Sclerosis by Bosentan [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports that the Phase 1/2 study of bosentan for early systemic sclerosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• TRACLEER (bosentan)

Snippet

Sponsor: Rikshospitalet University Hospital | Conditions: Systemic Sclerosis (Scleroderma) | Phase 1, Phase 2 | Status: TERMINATED